申请人:Delmar Chemicals Limited
公开号:US03966761A1
公开(公告)日:1976-06-29
This invention provides novel tertiary aminoindazole compounds of the following general formula: ##SPC1## Wherein R represents a hydrogen or halogen atom; R.sub.1 represents an alkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted aralkyl group; R.sub.2 and R.sub.3 both represent a lower alkyl or aralkyl group and W represents a branched chain alkylene group, and salts, especially acid addition and quaternary ammonium salts thereof, and processes for making them. Such compounds are pharmacologically active in that they exhibit antiinflammatory and analgesic effects so the invention also provides pharmaceutical compositions containing one or more of these compounds as the active ingredient. They are also useful anti-microbial agents.
这项发明提供了以下通式的新型三级胺吲唑化合物:其中R代表氢原子或卤素原子;R.sub.1代表烷基基团、取代或未取代的芳基团或取代或未取代的芳基基团;R.sub.2和R.sub.3均代表较低的烷基或芳基基团,W代表支链烷基基团,以及其盐,特别是酸加成盐和季铵盐,以及制备它们的方法。这些化合物在药理学上具有活性,表现出抗炎和镇痛效果,因此该发明还提供含有其中一个或多个这些化合物作为活性成分的药物组合物。它们还是有用的抗微生物剂。